Compare Cadila Healthcare with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs DISHMAN PHARMA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE DISHMAN PHARMA CADILA HEALTHCARE/
DISHMAN PHARMA
 
P/E (TTM) x 14.7 25.1 58.6% View Chart
P/BV x 2.9 3.3 85.7% View Chart
Dividend Yield % 1.4 0.7 214.9%  

Financials

 CADILA HEALTHCARE   DISHMAN PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
DISHMAN PHARMA
Mar-16
CADILA HEALTHCARE/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs558374 149.0%   
Low Rs362129 280.4%   
Sales per share (Unadj.) Rs116.3197.8 58.8%  
Earnings per share (Unadj.) Rs17.921.2 84.3%  
Cash flow per share (Unadj.) Rs23.134.7 66.6%  
Dividends per share (Unadj.) Rs3.502.00 175.0%  
Dividend yield (eoy) %0.80.8 95.8%  
Book value per share (Unadj.) Rs85.4179.9 47.5%  
Shares outstanding (eoy) m1,023.7480.69 1,268.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.3 310.8%   
Avg P/E ratio x25.711.9 216.8%  
P/CF ratio (eoy) x19.97.2 274.2%  
Price / Book Value ratio x5.41.4 384.8%  
Dividend payout %19.69.4 207.7%   
Avg Mkt Cap Rs m470,66420,306 2,317.9%   
No. of employees `00011.80.8 1,425.7%   
Total wages/salary Rs m18,5455,355 346.3%   
Avg. sales/employee Rs Th10,072.719,252.7 52.3%   
Avg. wages/employee Rs Th1,569.16,459.5 24.3%   
Avg. net profit/employee Rs Th1,547.72,064.1 75.0%   
INCOME DATA
Net Sales Rs m119,04915,961 745.9%  
Other income Rs m1,132265 426.5%   
Total revenues Rs m120,18116,226 740.7%   
Gross profit Rs m28,4754,103 694.0%  
Depreciation Rs m5,3881,091 494.0%   
Interest Rs m911944 96.5%   
Profit before tax Rs m23,3082,334 998.8%   
Minority Interest Rs m6280-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644624 905.1%   
Profit after tax Rs m18,2921,711 1,069.0%  
Gross profit margin %23.925.7 93.0%  
Effective tax rate %24.226.7 90.6%   
Net profit margin %15.410.7 143.3%  
BALANCE SHEET DATA
Current assets Rs m82,00511,018 744.3%   
Current liabilities Rs m60,7209,517 638.0%   
Net working cap to sales %17.99.4 190.1%  
Current ratio x1.41.2 116.7%  
Inventory Days Days73110 66.2%  
Debtors Days Days9835 282.2%  
Net fixed assets Rs m83,70316,304 513.4%   
Share capital Rs m1,024161 634.4%   
"Free" reserves Rs m86,42112,907 669.6%   
Net worth Rs m87,44514,516 602.4%   
Long term debt Rs m25,5514,189 609.9%   
Total assets Rs m180,65329,805 606.1%  
Interest coverage x26.63.5 765.9%   
Debt to equity ratio x0.30.3 101.2%  
Sales to assets ratio x0.70.5 123.1%   
Return on assets %10.68.9 119.3%  
Return on equity %20.911.8 177.5%  
Return on capital %22.017.5 125.4%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m42,6834,952 862.0%   
Fx outflow Rs m11,242697 1,613.4%   
Net fx Rs m31,4414,255 739.0%   
CASH FLOW
From Operations Rs m9,1932,786 329.9%  
From Investments Rs m-9,737-1,529 636.9%  
From Financial Activity Rs m515-941 -54.7%  
Net Cashflow Rs m-29316 -9.2%  

Share Holding

Indian Promoters % 74.8 61.4 121.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 3.7 224.3%  
FIIs % 5.9 12.7 46.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 22.1 49.8%  
Shareholders   44,069 46,261 95.3%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   NOVARTIS  TORRENT PHARMA  FRESENIUS KABI ONCO.  CIPLA  ABBOTT INDIA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 334 Points Lower; IT and Telecom Stocks Witness Huge Selling(Closing)

India share markets witnessed selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Oct 22, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS